Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06517186 · ClinicalTrials.gov registry record

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

A clinical trial of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Northwestern University.

Recruiting
Registry status
180
Enrollment target
6
Study locations

NCT06517186 is a study of Heart Failure and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 180 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06517186, a study of Heart Failure and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
180 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.

Study Locations (6)

Illinois

  • Northwestern University - Chicago

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Mass General Brigham - Boston

Minnesota

  • Mayo Clinic - Rochester

North Carolina

  • Wake Forest University - Winston-Salem

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-11-08
Est. Completion 2026-06

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT06517186

The ClinicalTrials.gov registry entry for NCT06517186 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT06517186 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Illinois, Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06517186 about?

NCT06517186 is a clinical study titled "Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction". The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treat...

What is the current status of trial NCT06517186?

This trial is currently recruiting. The enrollment target is 180 participants. The study started on 2024-11-08. Estimated completion is 2026-06.

What conditions does trial NCT06517186 study?

This clinical trial studies the following conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction.

Who is sponsoring clinical trial NCT06517186?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06517186 being conducted?

This trial has 6 study locations across Illinois, Maryland, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.